Variables | Univariate analysis | Multivariate analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P | aHR (95% CI) | P | aHR (95% CI) | P | aHR (95% CI) | P | aHR (95% CI) | P | |
FIGO stage | ||||||||||
III-IV (n = 290) vs. I-II (n = 48) | 4.973 (2.631–9.399) | < 0.001 | 2.729 (1.397–5.331) | 0.003 | 2.915 (1.494–5.687) | 0.002 | 2.933 (1.504–5.720) | 0.002 | 2.913 (1.494–5.677) | 0.002 |
Neoadjuvant chemotherapy | ||||||||||
Yes (n = 113) vs. No (n = 225) | 2.160 (1.639–2.845) | < 0.001 | 2.107 (1.572–2.823) | < 0.001 | 2.003 (1.497–2.680) | < 0.001 | 1.973 (1.471–2.646) | < 0.001 | 1.994 (1.489–2.671) | < 0.001 |
Operative time, h | ||||||||||
≥5.0 (n = 161) vs. <5.0 (n = 177) | 1.477 (1.125–1.938) | 0.005 | 1.331 (1.003–1.767) | 0.048 | 1.325 (0.998–1.759) | 0.052 | 1.358 (1.023–1.802) | 0.034 | 1.392 (1.048–1.849) | 0.022 |
Residual tumor after surgery | ||||||||||
Residual (n = 85) vs. R0 (n = 253) | 2.555 (1.897–3.442) | < 0.001 | 2.333 (1.719–3.168) | < 0.001 | 2.323 (1.713–3.150) | < 0.001 | 2.267 (1.671–3.076) | < 0.001 | 2.279 (1.681–3.091) | < 0.001 |
MAP under 65 mmHg, min | ||||||||||
Continuous (n = 338) | 1.002 (0.999–1.005) | 0.289 | ||||||||
≥30.0 (n = 107) vs. <30.0 (n = 231) | 1.423 (1.073–1.887) | 0.014 | 1.376 (1.035–1.830) | 0.028 | ||||||
MDPE (%) | ||||||||||
Continuous (n = 338) | 0.993 (0.981–1.005) | 0.244 | ||||||||
<−4.0 (n = 183) vs. ≥−4.0 (n = 155) | 1.349 (1.025–1.775) | 0.032 | 1.351 (1.024–1.783) | 0.033 | ||||||
Wobble (%) | ||||||||||
Continuous (n = 338) | 1.096 (1.032–1.165) | 0.003 | 1.082 (1.018–1.150) | 0.012 | ||||||
≥7.5 (n = 159) vs. <7.5 (n = 179) | 1.449 (1.106–1.900) | 0.007 | 1.445 (1.100–1.899) | 0.008 |